loadpatents
name:-0.053735017776489
name:-0.011586904525757
name:-0.008342981338501
Boyd; Brooks Patent Filings

Boyd; Brooks

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boyd; Brooks.The latest application filed is for "compositions and methods involving polymer, solvent and high viscosity liquid carrier material".

Company Profile
5.10.25
  • Boyd; Brooks - Emeryville CA
  • Boyd; Brooks - Berkeley CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods Involving Polymer, Solvent And High Viscosity Liquid Carrier Material
App 20220280646 - WRIGHT; Jeremy C. ;   et al.
2022-09-08
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
Grant 11,406,606 - Farr , et al. August 9, 2
2022-08-09
Methods Of Treating Doose Syndrome Using Fenfluramine
App 20220226262 - BOYD; Brooks ;   et al.
2022-07-21
Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
App 20220125743 - FARR; Stephen J. ;   et al.
2022-04-28
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 11,285,217 - Wright , et al. March 29, 2
2022-03-29
Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
App 20210393550 - FARR; Stephen J. ;   et al.
2021-12-23
Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
App 20210267916 - FARR; Stephen J. ;   et al.
2021-09-02
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
Grant 11,040,018 - Farr , et al. June 22, 2
2021-06-22
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20210015924 - WRIGHT; Jeremy C. ;   et al.
2021-01-21
Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
App 20200246281 - Kind Code
2020-08-06
Methods Of Treating Doose Syndrome Using Fenfluramine
App 20200170965 - BOYD; Brooks ;   et al.
2020-06-04
Formulation for inhibiting formation of 5-HT.sub.2B agonists and methods of using same
Grant 10,603,290 - Farr , et al.
2020-03-31
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20200085829 - WRIGHT; Jeremy C. ;   et al.
2020-03-19
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20190255179 - WRIGHT; Jeremy C. ;   et al.
2019-08-22
Formulation For Inhibiting Formation Of 5-ht2b Agonists And Methods Of Using Same
App 20190083425 - FARR; Stephen J. ;   et al.
2019-03-21
Formulation For Inhibiting Formation Of 5-ht2b Agonists And Methods Of Using Same
App 20190083424 - FARR; Stephen J. ;   et al.
2019-03-21
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 10,226,532 - Wright , et al.
2019-03-12
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20180140605 - WRIGHT; Jeremy C. ;   et al.
2018-05-24
Formulation For Inhibiting Formation Of 5-ht2b Agonists And Methods Of Using Same
App 20180055789 - FARR; Stephen J. ;   et al.
2018-03-01
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
App 20180036412 - WRIGHT; Jeremy C. ;   et al.
2018-02-08
Injectable controlled release composition comprising high viscosity liquid carrier
Grant 9,737,605 - Wright , et al. August 22, 2
2017-08-22
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20170143721 - WRIGHT; Jeremy C. ;   et al.
2017-05-25
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 9,572,812 - Wright , et al. February 21, 2
2017-02-21
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20160206618 - WRIGHT; Jeremy C. ;   et al.
2016-07-21
Needle Free Injectors
App 20160199579 - Boyd; Brooks ;   et al.
2016-07-14
Injectable Controlled Release Composition Comprising High Viscosity Liquid Carrier
App 20160038596 - WRIGHT; Jeremy C. ;   et al.
2016-02-11
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20140308352 - WRIGHT; Jeremy C. ;   et al.
2014-10-16
Needle-free injectors and design parameters thereof that optimize injection performance
Grant 8,734,384 - Boyd , et al. May 27, 2
2014-05-27
Piston Closures For Drug Delivery Capsules
App 20140142500 - NEWELL; GEOFF ;   et al.
2014-05-22
Needle-free Injectors And Design Parameters Thereof That Optimize Injection Performance
App 20120065615 - BOYD; BROOKS ;   et al.
2012-03-15
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
App 20050232899 - Balwani, Gul P. ;   et al.
2005-10-20
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
Grant 6,830,744 - Balwani , et al. December 14, 2
2004-12-14
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
App 20030223936 - Balwani, Gul ;   et al.
2003-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed